Related Experiment Video
Updated: Apr 21, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
EphA3 biology and cancer
Peter W Janes1, Christopher I Slape, Rae H Farnsworth
1Department of Biochemistry and Molecular Biology, Monash University , Victoria , Australia and.
Abstract:
Eph receptor tyrosine kinases control cell-cell interactions during normal and oncogenic development, and are implicated in a range of processes including angiogenesis, stem cell maintenance and metastasis. They are thus of great interest as targets for cancer therapy. EphA3, originally isolated from leukemic and melanoma cells, is presently one of the most promising therapeutic targets, with multiple tumor-promoting roles in a variety of cancer types. This review focuses on EphA3, its functions in controlling cellular behavior, both in normal and pathological development, and most particularly in cancer.
Insights
Eph receptor tyrosine kinases regulate cell interactions in development and cancer. EphA3, a key target, promotes tumors and is crucial in various cancers, making it a focus for cancer therapy research.
Area of Science:
- Molecular biology
- Cell biology
- Oncology
Background:
- Eph receptor tyrosine kinases (RTKs) are crucial regulators of cell-cell interactions.
- These interactions are vital in normal development and oncogenesis, influencing processes like angiogenesis, stem cell maintenance, and metastasis.
- RTKs are significant targets for developing novel cancer therapies.
Purpose of the Study:
- This review focuses on the Ephrin receptor A3 (EphA3).
- It examines EphA3's functions in normal and pathological cellular development.
- The review specifically highlights EphA3's roles in various cancer types and its potential as a therapeutic target.
Main Methods:
- Literature review
- Analysis of existing research on EphA3
- Synthesis of data on EphA3's function in normal and cancer cells
Main Results:
- EphA3 plays a critical role in controlling cellular behavior.
- Originally identified in leukemic and melanoma cells, EphA3 exhibits tumor-promoting functions across diverse cancers.
- EphA3 is implicated in key cancer processes including metastasis and angiogenesis.
Conclusions:
- EphA3 is a highly promising therapeutic target for cancer treatment.
- Understanding EphA3's multifaceted roles is essential for designing effective anti-cancer strategies.
- Further research into EphA3 signaling pathways could unlock new avenues for cancer therapy.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
The Tumor Microenvironment

